Skip to main content
SpringerLink
Log in

Ultrastructural evidence of thyroid damage in amiodarone-induced thyrotoxicosis

  • Case Report
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Amiodarone-induced thyrotoxicosis occurs in 2–12.1% of patients on chronic amiodarone treatment. In most cases its pathogenesis is related to iodine overload in the presence of preexisting thyroid abnormalities, such as multinodular or diffuse goiter or autonomous nodule. A minority of patients show apparently normal glands or pictures of non-autoimmune thyroiditis. However, there is recent evidence of a direct toxic effect of amiodarone, with consequent release of iodothyronines into the circulation. We report a patient with amiodarone-induced thyrotoxicosis with toxic thyroid effects demonstrated by electron microscopy in a fine-needle aspiration biopsy. There were three main pathologic findings: multilamellar lysosomal inclusions, intramitchondrial glycogen inclusions — both ultra-structural findings indicating thyroid cell damage — and a microscopic morphological pattern of thyroid cell hyperfunction. No inflammatory changes were found. Plasma thyroglobulin levels were high. The patient proved to be a non responder to simultaneousadministration of methimazole (starting dose 30 mg/day) and potassium perchlorate (1000 mg/day for 40 days), while still taking amiodarone, thus providingevidence against a possible pathogenetic role of iodine overload. Dexamethasone (starting dose 3 mg/day) was added to methimazole. After three months euthyroidism had been restored and plasma thyroglobulin level substantially decreased. Subsequent subclinical hypothyroidism developed, which persisted after stopping antithyroid treatment and required substitution treatment with levothyroxine. In view of the primary role of lysosome function in the proteolysis of thyroglobulin molecules and of the energy-requiring carrier-mediated transport of monoiodotyrosine across the lysosomal membrane for iodine salvage and reutilization, we suggest that the pathological lysosomal and mitochondrial changes observed could be an ultrastuctural marker for subsequent hypothyroidism in amiodarone-induced thyrotoxicosis. Our observations suggest the usefulness of ultrastructural thyroid evaluation and serial plasma thyroglobulin determinations to thoroughly evaluate the underlying pathogenetic mechanisms in amiodarone-associated thyrotoxicosis with apparently normal thyroid glands. Moreover, more knowledge of its pathogenesis could improve both prognostic stratification and treatment guides.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mason J.W. Amiodarone. N. Engl. J. Med. 316: 455, 1987.

    Article  PubMed  CAS  Google Scholar 

  2. Martino E., Safran M., Aghini-Lombardi F., Rajatanavin R., Lenziardi M., Fay M., Pacchiarotti A., Aronin N., Macchia E., Haffajee C., Odoguardi L., Love J., Bigalli A., Baschieri L., Pinchera A., Braverman L. Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann. Intern. Med. 101: 28, 1984.

    Article  PubMed  CAS  Google Scholar 

  3. Trip M.D., Wiersinga W., Plomp T.A. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am. J. Med. 91: 507, 1991.

    Article  PubMed  CAS  Google Scholar 

  4. Franklyn J.A., Sheppard M.C. Amiodarone and thyroid dysfunction. Trends Endocrinol. Metabol. 4: 128, 1993.

    Article  CAS  Google Scholar 

  5. Leung W-H., Pun K-K., Lau C-P., Wong C-K., Wang C. Amiodarone-induced thyroiditis. Am. Heart J. 118: 848, 1989.

    Article  PubMed  CAS  Google Scholar 

  6. Lambert M., Unger J., De Nayer P., Brohet C., Gangji D. Amiodarone-induced thyrotoxicosis suggestive of thyroid damage. J. Endocrinol. Invest. 13: 527, 1990.

    Article  PubMed  CAS  Google Scholar 

  7. Gudbjörnsson B., Kristinsson À., Geirsson G., Hreidarsson Á.B. Painful autoimmune thyroiditis occurring on amiodarone therapy. Acta Med. Scand. 221: 219, 1987.

    Article  PubMed  Google Scholar 

  8. Miaskiewicz S.L., Amico J.A., Follansbee W.P., Levey G.S. Amiodarone-associated thyrotoxicosis masquerading as painful thyroiditis. Ann. Intern. Med. 107: 118, 1987.

    Article  PubMed  CAS  Google Scholar 

  9. Savoie J.C., Massin J.P., Thomopoulos P., Leger F. Iodine-induced thyrotoxicosis in apparently normal thyroid glands. J. Clin. Endocrinol. Metab. 41: 685, 1975.

    Article  PubMed  CAS  Google Scholar 

  10. Smyrk T.C., Goellner J.R., Brennan M.D., Carney J.A. Pathology of the thyroid in amiodarone-associated thyrotoxicosis. Am. J. Surg. Pathol. 11: 197, 1987.

    Article  PubMed  CAS  Google Scholar 

  11. Farwell A.P., Abend S.L., Huang S.K.S., Patwardhan N.A., Braverman L.E. Thyroidectomy for amiodarone-induced thyrotoxicosis. JAMA 263: 1526, 1990.

    Article  PubMed  CAS  Google Scholar 

  12. Roti E., Minelli R., Gardini E., Bianconi L., Braverman L.E. Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. A possible consequence of a destructive process in the thyroid. Arch. Intern. Med. 153: 886, 1993.

    CAS  Google Scholar 

  13. Rajatanavin R., Braverman L.E. Euthyroid hyperthyroxinemia. J. Endocrinol. Invest. 6: 493, 1983.

    Article  PubMed  CAS  Google Scholar 

  14. Reichert L.J.M., de Rooy H.A.M. Treatment of amiodarone induced hyperthyroidism with potassium perchlorate and methimazole during amiodarone treatment. Br. Med. J. 298: 1547, 1989.

    Article  CAS  Google Scholar 

  15. Bonnyns M., Sterling I., Renard M., Bernard R., Demaret B., Bourdoux P. Dexamethasone treatment of amiodarone-induced thyrotoxicosis (AIT) with or without persistent administration of the drug. Acta Cardiol. 44: 235, 1989.

    PubMed  CAS  Google Scholar 

  16. Unger J. Serum thyroglobulin concentration may be a clue to the mechanism of amiodarone-induced thyrotoxicosis. J. Endocrinol. Invest. 11: 689, 1988.

    Article  PubMed  CAS  Google Scholar 

  17. Unger J. Amiodarone et thyroïde: l’effet Janus. Rev. Méd. Brux. 11: 89, 1990.

    Article  PubMed  CAS  Google Scholar 

  18. Van Herle A.J., Vassart G., Dumont J.E. Control of thyroglobulin synthesis and secretion (First of two parts). N. Engl. J. Med. 301: 239, 1979.

    Article  PubMed  Google Scholar 

  19. Weissel M. Suppression of thyroglobulin secretion in amiodarone iodine-induced thyrotoxicosis. J. Endocrinol. Invest. 11: 53, 1988.

    Article  PubMed  CAS  Google Scholar 

  20. Ringrose P.S., Parr M.A., McLaren M. Effects of anti-inflammatory and other compounds on the release of lysosomal enzymes from macrophages. Biochem. Pharmacol. 24: 607, 1975.

    Article  PubMed  CAS  Google Scholar 

  21. Cappiello E., Raggi U., Lo Presti F., Danna P., Dell’Orto S., Landoni M.T., Guzzetti S., Bozzi G. Longitudinal follow-up of amiodarone-induced hyperthyroidism and results of treatment with antithyroid drugs while continuing amiodarone therapy. New Trends Arrhyt. 7: 685, 1991.

    Google Scholar 

  22. Kaplan J., Ish-Shalom S. Goiter and hypothyroidism during re-treatment with amiodarone in a patient who previously experienced amiodarone-induced thyrotoxicosis. Am. J. Med. 90: 750, 1991.

    Article  PubMed  CAS  Google Scholar 

  23. Davies P.H., Franklyn J.A., Sheppard M.C. Treatment of amiodarone induced thyrotoxicosis with carbimazole alone and continuation of amiodarone. Br. Med. J. 305: 224, 1992.

    Article  CAS  Google Scholar 

  24. Greene H.L. for the CASCADE Investigators. The CASCADE study: randomized antiarrhythmic drug therapy in survivors of cardiac arrest in Seattle. Am. J. Cardiol. 72: 70F, 1993.

    CAS  Google Scholar 

  25. Roti E., Minelli R., Gardini E., Bianconi L., Gavaruzzi G., Ugolotti G., Neri T.M., Braverman L.E. Iodine-induced subclinical hypothyroidism in euthyroid subjects with a previous episode of amiodarone-induced thyrotoxicosis. J. Clin. Endocrinol. Metab. 75: 1273, 1992.

    PubMed  CAS  Google Scholar 

  26. Dake M.D., Madison J.M., Montgomery C.K., Shellito J.E., Hinchcliffe W.A., Winkler M.L., Bainton D.F. Electron microscopic demonstration of lysosomal inclusion bodies in lung, liver, lymph nodes, and blood leukocytes of patients with amiodarone pulmonary toxicity. Am. J. Med. 78: 506, 1985.

    Article  PubMed  CAS  Google Scholar 

  27. Adams P.C., Holt D.W., Storey G.C.A., Morley A.R., Callaghan J., Campbell R.W.F. Amiodarone and its desethyl metabolite: tissue distribution and morphologic changes during long-term therapy. Circulation 72: 1064, 1985.

    Article  PubMed  CAS  Google Scholar 

  28. Hostetler K.Y., Vande Berg J., Aldern K.A., Brophy G.T. Effect of amiodarone on the phospholipid and lamellar body content of lymphoblasts in vitro and peripheral blood lymphocytes in vivo. Biochem. Pharmacol. 41: 1007, 1991.

    Article  PubMed  CAS  Google Scholar 

  29. Liu F.L-W., Cohen R.D., Downar E., Butany J.W., Edelson J.D., Rebuck A.S. Amiodarone pulmonary toxicity: functional and ultrastructural evaluation. Thorax 41: 100, 1986.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  30. Riva E., Marchi S., Pesenti A., Bizzi A., Cini M., Veneroni E., Tavani E., Boeri R., Bertani T., Latini R. Amiodarone induced phospholipidosis. Biochemical, morphological and functional changes in the lungs of rats chronically treated with amiodarone. Biochem. Pharmacol. 36: 3209, 1987.

    CAS  Google Scholar 

  31. Maron B.J., Ferrans V.J. Ultrastructural features of hypertrophied human ventricular myocardium. Prog. Cardiovasc. Dis. 21: 207, 1978.

    Article  PubMed  CAS  Google Scholar 

  32. Roberts W.C., Ferrans V.J. Pathologic anatomy of cardiomyopathies. Idiopathic dilated and hypertrophic types, infiltrative types and endomyocardial disease with and without eosinophilia. Hum. Pathol. 6: 287, 1975.

    CAS  Google Scholar 

  33. Ghadially F.N. Mitochondria. In: Ghadially F.N. (Ed.), Ultrastructural pathology of the cell and matrix. Butterworths, London, 1988, p. 288.

    Google Scholar 

  34. Phillips M.J., Poucell S., Patterson J., Valencia P. Drug and toxic effects. In: Phillips M.J., Poucell S., Patterson J., Valencia P. (Eds.), The liver: an atlas and text of ultrastructural pathology. Raven Press, New York, NY, 1987, p. 162.

    Google Scholar 

  35. Van Herle A.J., Vassart G., Dumont J.E. Control of thyroglobulin synthesis and secretion (Second of two parts). N. Engl. J. Med. 301: 307, 1979.

    Article  PubMed  Google Scholar 

  36. Unger J., Ketelbant P. Inhibition by monensin of dog thyroid secretion in vitro. Endocrinology 123: 66, 1988.

    Article  PubMed  CAS  Google Scholar 

  37. Tietze F., Kohn L.D., Kohn A.D., Bernardini I, Andersson H.C., Adamson M.D., Harper G.S., Gahl W.A. Carrier-mediated transport of monoiodotyrosine out of thyroid cell lysosomes. J. Biol. Chem. 264: 4762, 1989.

    PubMed  CAS  Google Scholar 

  38. Andersson H.C., Kohn L.D., Bernardini I., Blom H.J., Tietze F., Gahl W.A. Characterization of lysosomal monoiodotyrosine transport in rat thyroid cells. Evidence for transport by system h. J. Biol. Chem. 265: 10950, 1990.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Divisione di Cardiologia, Istituto di Scienze Biomediche Luigi Sacco, Ospedale Luigi Sacco, Via G.B. Grassi 74, 20157, Milano, Italy

    Emanuele Cappiello M.D.

  2. V Cattedra di Anatomia Patologica, Istituto di Scienze Biomediche Luigi Sacco, Ospedale Luigi Sacco, Milano, Italy

    R. Boldorini & A. Tosoni

  3. Divisione di Patologia Chirurgica, Istituto di Scienze Biomediche Luigi Sacco, Ospedale Luigi Sacco, Milano, Italy

    S. Piraneo

  4. Servizio di Endocrinologia, Istituto di Scienze Biomediche Luigi Sacco, Ospedale Luigi Sacco, Milano, Italy

    U. Raggi

  5. Istituto Farmacologico Mario Negri, Milano, Italya

    R. Bernasconi

Authors
  1. Emanuele Cappiello M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Boldorini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Tosoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Piraneo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Bernasconi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. U. Raggi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cappiello, E., Boldorini, R., Tosoni, A. et al. Ultrastructural evidence of thyroid damage in amiodarone-induced thyrotoxicosis. J Endocrinol Invest 18, 862–868 (1995). https://doi.org/10.1007/BF03349834

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03349834

Key-words

Search

Navigation